Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–4 of 4 stories
En Carta Diagnostics' EC Pocket Lyme test has received FDA Breakthrough Device Designation, aiming to improve diagnosis for the approximately 476,000 new Lyme disease cases reported annually in the US. This designation may expedite the test's development and review process.
Read full storyClinical trials for new Lyme disease vaccines are currently underway, but no vaccine is available yet. This highlights ongoing efforts to address Lyme disease prevention amid rising cases.
The CDC highlights Lyme Disease Awareness Month, urging Americans to educate themselves about this tickborne disease. The campaign aims to promote protective measures for those in areas with Lyme disease activity.
The CDC reports that Lyme disease cases have more than doubled since 1991, highlighting a significant public health concern. Notably, 93% of these cases are concentrated in just 10 states, emphasizing the need for targeted awareness and prevention efforts.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.